HSCT offers a transformative approach for select patients with refractory SSc, SLE, RA, DADA2, ANCA-associated vasculitis, TA, and JIA, achieving long-term, drug-free remission in some. Future research should optimize conditioning protocols, refine patient selection, and assess long-term outcomes to maximize HSCT benefits and minimize risks.
Building similarity graph...
Analyzing shared references across papers
Loading...
Nandana Suresh
D. R. Spoorthy Raj
Harshwardhan Patil
International Journal of Rheumatic Diseases
JSS Academy of Higher Education and Research
Apollo Hospitals
JSS Medical College and Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Suresh et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69b6069b83145bc643d1ca57 — DOI: https://doi.org/10.1111/1756-185x.70604